{"nct_id":"NCT00787410","title":"An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma","status":"COMPLETED","status_verified_date":"2012-06","start_date":"2003-09","start_date_type":null,"primary_completion_date":"2008-04","primary_completion_date_type":"ACTUAL","completion_date":"2008-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}